News & SEC Filings
News
June 10 2021Regulatory
Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration to Develop and Commercialize Ensifentrine in Greater China
$40 million upfront including $25 million cash and $15 million in equity in Nuance Biotech (parent company). Up to $179 million in potential clinical, regulatory, and commercial milestone payments plus tiered double-digit royalties. Nuance Pharma is responsible for all costs related to development and commercialization of ensifentrine in China.
May 25 2021Regulatory
Verona Pharma to Present at Jefferies Virtual Healthcare Conference
LONDON and RALEIGH, N.C., May 25, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive Officer and President, will present a company overview at the
May 4 2021Regulatory
Verona Pharma to Present Expanded Analysis of Phase 2b COPD Data with Ensifentrine at the American Thoracic Society 2021 International Conference
Posters highlight ensifentrine’s safety profile and its potential to improve lung function and quality of life irrespective of COPD severity LONDON and RALEIGH, N.C., May 04, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company
April 29 2021Regulatory
Verona Pharma Reports First Quarter 2021 Financial Results and Provides Corporate Update
ENHANCE Phase 3 program enrollment continues on track to complete in 2H21 Board strengthened with NED appointment of Lisa Deschamps Conference call today at 9:00 a.m. EDT / 2:00 p.m. BST LONDON and RALEIGH, N.C., April 29, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”
April 27 2021Regulatory
Verona Pharma Announces Publication of Phase 2b Dose-Ranging COPD Data in the International Journal of Chronic Obstructive Pulmonary Disease
Ensifentrine improves lung function and quality of life when added to maintenance tiotropium LONDON and RALEIGH, N.C., April 27, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces
SEC Filings
| Date | Description | Form | Filing Group | View |
|---|---|---|---|---|
| Jun 11 2021 | Report of unscheduled material events or corporate event | 8-K | Current Reports | |
| May 05 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| May 05 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| May 05 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| May 05 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| May 05 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| May 05 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| May 05 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| May 03 2021 | Report of unscheduled material events or corporate event | 8-K | Current Reports | |
| Apr 29 2021 | Quarterly report which provides a continuing view of a company's financial position | 10-Q | Quarterly Filings | |
| Apr 29 2021 | Report of unscheduled material events or corporate event | 8-K | Current Reports | |
| Mar 29 2021 | EFFECT | EFFECT | Other | |
| Mar 25 2021 | EFFECT | EFFECT | Other | |
| Mar 19 2021 | Simplified registration form | S-3 | Registration Statements | |
| Mar 19 2021 | Official notification to shareholders of matters to be brought to a vote ("Proxy") | DEF 14A | Proxy Filings | |
| Mar 19 2021 | Post-effective amendment to an S-Type filing | POS AM | Registration Statements | |
| Mar 03 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| Mar 03 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| Mar 03 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| Mar 03 2021 | Initial filing by director officer or owner of more than ten percent. | 3 | 3,4,5 | |
| Mar 02 2021 | Report of unscheduled material events or corporate event | 8-K | Current Reports | |
| Feb 25 2021 | Annual report which provides a comprehensive overview of the company for the past year | 10-K | Annual Filings | |
| Feb 25 2021 | Report of unscheduled material events or corporate event | 8-K | Current Reports | |
| Feb 16 2021 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| Feb 05 2021 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| Feb 03 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| Feb 03 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| Feb 03 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| Feb 03 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| Feb 03 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| Feb 01 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| Feb 01 2021 | Statement of changes in beneficial ownership of securities | 4 | 3,4,5 | |
| Jan 25 2021 | Report of unscheduled material events or corporate event | 8-K | Current Reports | |
| Jan 05 2021 | Initial filing by director officer or owner of more than ten percent. | 3 | 3,4,5 | |
| Jan 05 2021 | An amendment to a 3 filing. Non-EDGAR filing | 3/A | 3,4,5 | |
| Jan 05 2021 | Initial filing by director officer or owner of more than ten percent. | 3 | 3,4,5 | |
| Jan 04 2021 | Initial filing by director officer or owner of more than ten percent. | 3 | 3,4,5 | |
| Jan 04 2021 | Form of prospectus reflecting facts events constituting substantive change from last form | 424B3 | Registration Statements | |
| Jan 04 2021 | Initial filing by director officer or owner of more than ten percent. | 3 | 3,4,5 | |
| Jan 04 2021 | Initial filing by director officer or owner of more than ten percent. | 3 | 3,4,5 | |
| Jan 04 2021 | Initial filing by director officer or owner of more than ten percent. | 3 | 3,4,5 | |
| Jan 04 2021 | Initial filing by director officer or owner of more than ten percent. | 3 | 3,4,5 | |
| Dec 30 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Nov 24 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Nov 12 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Oct 29 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Oct 05 2020 | An amendment to a SC 13D filing | SC 13D/A | Other | |
| Sep 25 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Sep 22 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Sep 14 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Aug 27 2020 | EFFECT | EFFECT | Other | |
| Aug 27 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Aug 25 2020 | Amendment to a previously filed 6-K | 6-K/A | Current Reports | |
| Aug 25 2020 | This filing is a pre-effective amendment to an F-1 filing | F-1/A | Registration Statements | |
| Aug 20 2020 | Securities offered to employees pursuant to employee benefit plans | S-8 | Registration Statements | |
| Aug 19 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Aug 17 2020 | Registration statement for certain foreign private issuers | F-1 | Registration Statements | |
| Aug 14 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Aug 10 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Aug 03 2020 | An amendment to a SC 13D filing | SC 13D/A | Other | |
| Jul 31 2020 | An amendment to a SC 13D filing | SC 13D/A | Other | |
| Jul 24 2020 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| Jul 24 2020 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| Jul 22 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Jul 20 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Jul 16 2020 | Amendment to a previously filed 20-F | 20-F/A | Annual Filings | |
| May 14 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Apr 30 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Apr 30 2020 | Securities offered to employees pursuant to employee benefit plans | S-8 | Registration Statements | |
| Apr 16 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Apr 14 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Apr 06 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Mar 30 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Mar 10 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Feb 27 2020 | Registration of securities of foreign private issuers pursuant to section 12(b) or (g) | 20-F | Annual Filings | |
| Feb 05 2020 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| Feb 04 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Jan 17 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Nov 29 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Nov 22 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Nov 22 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Nov 05 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Sep 19 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Aug 14 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Aug 08 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Aug 07 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Jun 05 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| May 14 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| May 07 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| May 03 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Apr 12 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Apr 02 2019 | Filing by person(s) reporting owned shares of common stock in a public company >5% | SC 13D | Other | |
| Mar 26 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Mar 26 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Mar 19 2019 | Registration of securities of foreign private issuers pursuant to section 12(b) or (g) | 20-F | Annual Filings | |
| Mar 12 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Feb 28 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Feb 12 2019 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| Feb 11 2019 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| Jan 04 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Nov 06 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Sep 25 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Aug 14 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Aug 07 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Jun 28 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Jun 04 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Jun 01 2018 | EFFECT | EFFECT | Other | |
| May 22 2018 | Registration statement for certain foreign private issuers offered for certain transactions | F-3 | Registration Statements | |
| May 08 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| May 04 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| May 04 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Apr 18 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Mar 29 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Mar 22 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Feb 27 2018 | Annual Report of foreign issuer rules 13 and 15(d) of the Securities Exchange Act | 20-F | Annual Filings | |
| Feb 13 2018 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| Feb 06 2018 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| Jan 26 2018 | An amendment to a SC 13D filing | SC 13D/A | Other | |
| Nov 09 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Sep 21 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Sep 12 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Aug 24 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| Aug 08 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| May 26 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| May 18 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| May 12 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| May 09 2017 | Filing by person(s) reporting owned shares of common stock in a public company >5% | SC 13D | Other | |
| May 09 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| May 08 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| May 08 2017 | Filing by person(s) reporting owned shares of common stock in a public company >5% | SC 13D | Other | |
| May 08 2017 | Filing by person(s) reporting owned shares of common stock in a public company >5% | SC 13D | Other | |
| May 05 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| May 05 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| May 03 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| May 01 2017 | CT ORDER | CT ORDER | Other | |
| Apr 28 2017 | Securities offered to employees pursuant to employee benefit plans | S-8 | Registration Statements | |
| Apr 28 2017 | Form of prospectus disclosing information facts events covered in both forms 424B1 424B3 | 424B4 | Registration Statements | |
| Apr 26 2017 | This filing is a pre-effective amendment to an F-1 filing | F-1/A | Registration Statements | |
| Apr 26 2017 | EFFECT | EFFECT | Other | |
| Apr 26 2017 | EFFECT | EFFECT | Other | |
| Apr 26 2017 | Registration of up to an additional 20% of securities for an offering filed on an F-1 | F-1MEF | Registration Statements | |
| Apr 21 2017 | CERTNAS | CERTNAS | Other | |
| Apr 19 2017 | CERTNAS | CERTNAS | Other | |
| Apr 19 2017 | Registration of certain classes of securities 12(b) of the Securities Exchange Act | 8-A12B | Registration Statements | |
| Apr 18 2017 | This filing is a pre-effective amendment to an F-1 filing | F-1/A | Registration Statements | |
| Apr 18 2017 | Registration of depository shares evidenced by American Depository Receipts | F-6 | Registration Statements | |
| Apr 03 2017 | Registration statement for certain foreign private issuers | F-1 | Registration Statements | |
| Feb 13 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other |
Verona Pharma
Investor Information
© Verona Pharma plc 2021. All rights reserved